Scilex Holding Company Common Stock

$8.460
USD
Last updated on --.
24h volume121.24K
24h highest8.9900 USD
24h lowest8.2000 USD
24h Price movement-2.76%

SCLX recent prices

24 Hours
-2.76%-$0.24
30 days
+32.98%+$2.170
60 days
+46.81%+$2.790
90 days
+4.59%+$0.38

Key data

Previous close8.7000 USD
Market cap49.23M USD
Volume121.24K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-59.6700 USD
Net income (FY)-393.62M USD
Revenue (FY)33.86M USD
Last report dateMay 20, 2026

About Scilex Holding Company Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersPALO ALTO
Employees (FY)34.00
Revenue per employee (FY)995.94K USD
Net income per employee (FY)-11.58M USD
Listed onNasdaq
Official website

SCLX conversion tables

SCLXSCLX
USDUSD
0.5 SCLX4.230 USD
1 SCLX8.460 USD
5 SCLX42.3 USD
10 SCLX84.6 USD
USDUSD
SCLXSCLX
0.5 USD0.059102 SCLX
1 USD0.1182 SCLX
5 USD0.59102 SCLX
10 USD1.182 SCLX

FAQ

SCLX is trading at $8.460, -2.76% over the last 24 hours. Track live moves on the price chart at the top of this page.
The SCLX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. SCLX is currently trading at $8.460, -2.76% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on SCLX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. SCLX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from SCLX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against SCLX's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Scilex Holding Company Common Stock's market cap is currently 49.23M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume121.24K
24h highest8.9900 USD
24h lowest8.2000 USD
24h Price movement-2.76%
SCLXSCLX
USDUSD
Start trade with SCLX Perpetual